| 1 |
Goldhaber SZ, Haire WD, Feldstein ML, Miller M, Toltzis R, Smith JL, et al. Alteplase versus heparin in acute pulmonary embolism: randomised trial assessing right-ventricular function and pulmonary perfusion. Lancet. 1993; 341(8844):507-11.
pmid: 8094768
|
| 2 |
Konstantinides S, Geibel A, Heusel G, Heinrich F, Kasper W, Management Strategies and Prognosis of Pulmonary Embolism-3 Trial Investigators. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism. N Engl J Med. 2002; 347(15):1143-50.
doi: 10.1056/NEJMoa021274
|
| 3 |
Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th Ed: American College of Chest Physicians Evidence-based Clinical Practice Guidelines. Chest. 2012; 141(2 suppl):e419S-96S.
doi: 10.1378/chest.11-2301
|
| 4 |
Kearon C, Akl EA, Ornelas J, Blaivas A, Jimenez D, Bounameaux H, et al. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report. Chest. 2016; 149(2):315-52.
doi: S0012-3692(15)00335-9
pmid: 26867832
|
| 5 |
Goldhaber SZ. A contemporary approach to thrombolytic therapy for pulmonary embolism. Vasc Med Lond Engl. 2000; 5(2):115-23.
|
| 6 |
Chatterjee S, Chakraborty A, Weinberg I, Kadakia M, Wilensky RL, Sardar P, et al. Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis. JAMA. 2014; 311(23):2414-21.
doi: 10.1001/jama.2014.5990
pmid: 24938564
|
| 7 |
Fiumara K, Kucher N, Fanikos J, Goldhaber SZ. Predictors of major hemorrhage following fibrinolysis for acute pulmonary embolism. Am J Cardiol. 2006; 97(1):127-9.
pmid: 16377297
|
| 8 |
Liu YC, Qi YM, Zhang H, Walline J, Zhu HD. A survey of ventilation strategies during cardiopulmonary resuscitation. World J Emerg Med. 2019; 10(4):222-7.
doi: 10.5847/wjem.j.1920-8642.2019.04.005
|
| 9 |
Sklar MC, Sy E, Lequier L, Fan E, Kanji HD. Anticoagulation practices during venovenous extracorporeal membrane oxygenation for respiratory failure. A systematic review. Annals ATS. 2016; 13(12):2242-50.
doi: 10.1513/AnnalsATS.201605-364SR
|
| 10 |
Mazzeffi M, Greenwood J, Tanaka K, Menaker J, Rector R, Herr D, et al. Bleeding, transfusion, and mortality on extracorporeal life support: ECLS working group on thrombosis and hemostasis. Ann Thorac Surg. 2016; 101(2):682-9.
doi: 10.1016/j.athoracsur.2015.07.046
pmid: 26443879
|
| 11 |
Corsi F, Lebreton G, Bréchot N, Hekimian G, Nieszkowska A, Trouillet JL, et al. Life-threatening massive pulmonary embolism rescued by venoarterial-extracorporeal membrane oxygenation. Crit Care Lond Engl. 2017; 21(1):76.
doi: 10.1186/s13054-017-1655-8
|
| 12 |
Al-Bawardy R, Rosenfield K, Borges J, Young MN, Albaghdadi M, Rosovsky R, et al. Extracorporeal membrane oxygenation in acute massive pulmonary embolism: a case series and review of the literature. Perfusion. 2019; 34(1):22-8.
doi: 10.1177/0267659118786830
pmid: 30009670
|
| 13 |
Munakata R, Yamamoto T, Hosokawa Y, Tokita Y, Akutsu K, Sato N, et al. Massive pulmonary embolism requiring extracorporeal life support treated with catheter-based interventions. Int Heart J. 2012; 53(6):370-4.
pmid: 23258138
|
)
